Has anyone used Enhertu for HER2-positive breast cancer, and what side effects did you experience?
Enhertu (trastuzumab deruxtecan) is an antibody-drug conjugate approved for HER2-positive breast cancer. It works by targeting HER2 proteins on cancer cells and delivering chemotherapy directly to them, which helps limit Show Full Answer
Has anyone used Enhertu for HER2-positive breast cancer, and what side effects did you experience?
Enhertu (trastuzumab deruxtecan) is an antibody-drug conjugate approved for HER2-positive breast cancer. It works by targeting HER2 proteins on cancer cells and delivering chemotherapy directly to them, which helps limit damage to healthy tissue.
Recent studies show promising results. When combined with Perjeta (pertuzumab), Enhertu reduced the risk of disease progression or death by 44% compared to standard treatment in people with HER2-positive metastatic breast cancer. This combination kept cancer from progressing for more than three years in some cases.
While the search results don't detail specific side effects members experienced, it's important to discuss potential side effects with your oncologist before starting treatment. Since Enhertu delivers chemotherapy directly to cancer cells, you may experience side effects related to both the targeted therapy and chemotherapy components.
If you're considering Enhertu or currently taking it, your care team can help you manage any side effects and determine if this treatment is right for your situation.
April 16
Join
Your Privacy Choices
